1. Screening Libraries
  2. Protein Tyrosine Kinase Compound Library

Protein Tyrosine Kinase Compound Library

Cat. No.: HY-L016
Library Contents: XLSX PDF

A unique collection of 292 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 292 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

•   Targets such as VEGFR, ALK, Btk, Bcr-Abl, c-Met/HGFR, EGFR, FGFR, Insulin Receptor, JAK, PDGFR, etc.

•   A useful tool for the research for PTK-related diseases, such as cancer.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some protein kinase inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active and cell permeable.

•   Rich documentation with structure, IC50 and summary.

•   NMR and HPLC to ensure the high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 292 protein kinase inhibitors supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Protein Tyrosine Kinase Compound Library

Source: MedChem Express

Contents of Protein Tyrosine Kinase Compound Library

Plate layout: HY-L016-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Ginsenoside Rb1 7-Hydroxy-4-chromone AG 18 MNS Trapidil SU5416 Piceatannol TPI-1 Chrysophanol RG13022 Empty
b Empty Formononetin Genistein Butein RG14620 GW 441756 HA-100 PP1 Tyrphostin A9 Y15 Scutellarein Empty
c Empty IRAK inhibitor 1 AG-490 SU 5402 ID-8 Nocodazole PP2 MCB-613 AG1024 Tyrphostin AG 528 IRAK inhibitor 2 Empty
d Empty TSU-68 AT13148 AG-1478 Tyrphostin AG 879 1-Naphthyl PP1 PP121 AG 555 Fasudil (Hydrochloride) PD158780 KW-2449 Empty
e Empty Oglufanide ZM 306416 DPH AT7867 NVP-BVU972 PRT-060318 PQ401 SSR128129E 1-Naphthyl PP1 (hydrochloride) TPX-0005 Empty
f Empty ISCK03 CH5183284 R1530 SAR131675 SGX-523 LFM-A13 PD153035 TCS 359 PF06650833 GW2580 Empty
g Empty PD168393 Tivantinib Brivanib MSDC 0160 AIM-100 SU6656 PF-04217903 SB1317 Src Inhibitor 1 Motesanib Empty
h Empty GNF-2 Linifanib ENMD-2076 JNJ-38877605 TAK-659 (hydrochloride) CL-387785 PLX647 EAI045 WP1130 SNS-062 Empty

Plate layout: HY-L016-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BIBX 1382 Dovitinib Fruquintinib Erlotinib IRAK-1-4 Inhibitor I PD-166866 Toceranib IRAK inhibitor 6 Sunitinib BLZ945 Empty
b Empty NVP-ACC789 PF-06463922 ANA-12 Telatinib AT7867 (dihydrochloride) GS-9973 NT157 INCB28060 AXL1717 GSK2256098 Empty
c Empty KRN-633 CP-673451 Pexidartinib GNF-5 Vatalanib (dihydrochloride) CHIR-124 Linsitinib AVL-292 NVP-BAW2881 Lenvatinib Empty
d Empty Icotinib (Hydrochloride) LOXO-101 AZ191 Erlotinib (Hydrochloride) PRT062607 (Hydrochloride) CUDC-101 Pazopanib XL228 S49076 PCI-32765 Empty
e Empty AEE788 UNC2250 Brivanib (alaninate) SU14813 AZM475271 PD173955 OSI-930 Crenolanib LY2874455 Cerdulatinib Empty
f Empty Erdafitinib Gefitinib AZD2932 Amuvatinib AZD-3463 Crizotinib Cediranib SUN11602 ONO-4059 Tivozanib Empty
g Empty SGI-7079 ONO-4059 (analog) (-)-Epigallocatechin Gallate AZD3759 BMS-754807 BAY 61-3606 (dihydrochloride) AMG-337 AZD4547 UNC2881 Sorafenib Empty
h Empty Acalabrutinib JI-101 Pelitinib Mubritinib PF-04217903 (methanesulfonate) BMS-794833 NVP-TAE 226 Ki8751 CP-724714 LY2784544 Empty

Plate layout: HY-L016-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Dacomitinib R406 (free base) Sapitinib Pazopanib (Hydrochloride) PF-03814735 Vandetanib UNC2025 NVS-PAK1-1 BMS-536924 Irbinitinib Empty
b Empty Dovitinib (lactate) CH5424802 Regorafenib AZ-5104 Afatinib Olmutinib Crizotinib (hydrochloride) Dasatinib Bucladesine (calcium salt) DCC-2618 Empty
c Empty Poziotinib Bucladesine (sodium salt) PF-573228 EMD-1214063 Apatinib Imatinib WZ4002 Mirk-IN-1 Masitinib CNX-774 Empty
d Empty AZD-9291 Regorafenib (monohydrate) PND-1186 Cabozantinib NVP-BHG712 KX2-391 (dihydrochloride) PF-562271 BLU9931 TG101209 Altiratinib Empty
e Empty Defactinib eCF506 BMS 777607 UNC2025 (hydrochloride) TP-0903 MGCD-265 analog ALK inhibitor 2 RAF265 CH5424802 (Hydrochloride) Regorafenib (Hydrochloride) Empty
f Empty H-89 (dihydrochloride) PD173074 Dasatinib (hydrochloride) LOXO-101 (sulfate) KX2-391 (Mesylate) ALK-IN-1 Nilotinib AST 487 Lck Inhibitor FLT3-IN-1 Empty
g Empty Ponatinib GZD824 GSK1838705A GNF-5837 BIBF 1120 Saracatinib CNX-2006 Defactinib (hydrochloride) GNF-7 TAK-285 Empty
h Empty NPS-1034 LY2801653 DDR1-IN-1 Gilteritinib BPR1J-097 Hydrochloride DCC-2036 CO-1686 Ningetinib Neratinib LDK378 Empty

Plate layout: HY-L016-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SU14813 (maleate) Canertinib (dihydrochloride) NVP-BGJ398 LDC1267 Entrectinib Quizartinib Flumatinib Tandutinib Cediranib (maleate) BMS-599626 (Hydrochloride) Empty
b Empty SU11274 WH-4-023 Motesanib (Diphosphate) Bafetinib Belizatinib CGI-1746 CEP-37440 ASP3026 Lapatinib Nilotinib (monohydrochloride monohydrate) Empty
c Empty Brigatinib Imatinib (Mesylate) A 419259 (trihydrochloride) Masitinib (mesylate) AZD-9291 (mesylate) Avitinib (maleate) KRCA-0008 Gilteritinib hemifumarate EG00229 Neohesperidin dihydrochalcone Empty
d Empty NVP-TAE 684 R788(prodrug of R406) R406 Sitravatinib LDK378 (dihydrochloride) Foretinib FIIN-2 CEP-28122 (mesylate salt) Cabozantinib (S-malate) CO-1686 (hydrobromide) Empty
e Empty Sorafenib (Tosylate) PHA-665752 BIBF 1120 (esylate) Flumatinib (mesylate) GDC-0853 PF-562271 (besylate) SCR-1481B1 Afatinib (dimaleate) Ningetinib Tosylate R788 (disodium hexahydrate) Empty
f Empty GSK1904529A Lapatinib (ditosylate) Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Protein Tyrosine Kinase Compound Library
Cat. No.:
HY-L016
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.